Pabuaya, Cristine Mae .

HRN: 28-64-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
CO-AMOXICLAV 625MG (TAB)
03/06/2026
03/12/2026
PO
625mg
BID
Sp 1 LTCS, Prom
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines